hormone receptor positive

https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.984454/full Frontiers | Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human... Cystic brain metastases in patients with breast cancer are rare. They have a worse prognosis than solid brain metastases, and they are less sensitive to radi... hormone receptor positive for the https://www.breastcancer.org/research-news/prolia-reduces-recurrence-risk-for-some Prolia Reduces Recurrence Risk of Hormone-Receptor-Positive Disease in Women Taking Aromatase... A study has found that Prolia improved disease-free survival for postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer... hormone receptor positive https://www.breastcancer.org/podcast/tnbc-can-change-hormone-rececptor-status-when-recurring Podcast: TNBC May Be Hormone Receptor-Positive if It Recurs If triple-negative breast cancer comes back, the recurrence may be hormone receptor-positive. Can hormonal therapy help reduce recurrence risk? hormone receptor positive may be podcast tnbc https://www.mdanderson.org/newsroom/archived-news/ribociclib-plus-hormone-therapy-extends-survival-for-patients-with-premenopausal-advanced-hormone-receptor-positive-breast-cancer.h00-159303045.html ARCHIVED: Survival for advanced hormone receptor-positive breast cancer extended with ribociclib |... Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone... hormone receptor positive for advanced https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.674192/full Frontiers | The Immunology of Hormone Receptor Positive Breast Cancer Immune checkpoint blockade (ICB) has revolutionized the treatment of cancer patients. The main focus of ICB has been on reinvigorating the adaptive immune re... hormone receptor positive frontiers immunology breast cancer https://www.mayo.edu/research/clinical-trials/cls-20151020 Everolimus And Letrozole In Treating Patients With Recurrent Hormone Receptor Positive Ovarian,... Learn more about services at Mayo Clinic. hormone receptor positive https://www.breastcancer.org/research-news/faslodex-better-w-ibrance-for-hr-pos-mets Faslodex Plus Ibrance Better Than Faslodex Alone for Metastatic, Hormone Receptor-Positive Disease:... Ibrance plus Faslodex is better than Faslodex alone for metastatic, hormone receptor-positive disease that has stopped responding to hormonal therapy. hormone receptor positive better than https://www.breastcancer.org/research-news/aspirin-ibuprofen-may-reduce-risk-for-some Aspirin, Ibuprofen May Reduce Recurrence Risk for Hormone-Receptor-Positive Disease Two studies on NSAIDs and breast cancer suggest that these medicines may help reduce the risk of recurrence of hormone-receptor-positive breast cancer in... hormone receptor positive aspirin ibuprofen may reduce https://www.nice.org.uk/guidance/ta612 Overview | Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive... Evidence-based recommendations on neratinib (Nerlynx) for extended adjuvant treatment of hormone receptor-positive, human epidermal growth factor receptor 2... hormone receptor positive adjuvant treatment overview neratinib extended https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hormone-receptor-positive Definition of hormone receptor positive - NCI Dictionary of Cancer Terms - NCI NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. hormone receptor positive definition of nci dictionary cancer https://www.breastcancer.org/research-news/chemo-for-some-triple-pos-bc-improves-survival Chemotherapy for Certain Small, Hormone-Receptor-Positive, HER2-Positive Breast Cancers Seems to... A study suggests that women diagnosed with cancers 8-10 mm in size had better survival when they were treated with chemotherapy after surgery. hormone receptor positive for certain https://www.esmo.org/meeting-calendar/esmo-breast-cancer-2025/industry-sponsored-satellite-symposia/hormone-receptor-positive-metastatic-breast-cancer-tailoring-patient-care-from-et-based-approaches-to-adcs Hormone Receptor-Positive Metastatic Breast Cancer: Tailoring Patient Care from ET-Based Approaches... hormone receptor positive metastatic breast cancer https://www.researchandmarkets.com/reports/5951362/early-stage-hormone-receptor-positive-and Early Stage Hormone Receptor Positive & HER2Positive Breast Cancer (LATAM) - Pipeline Insight, 2025 hormone receptor positive early stage https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1272602/full Frontiers | Treatment options for patients with hormone receptor-positive, HER2-negative... Breast cancer is the most commonly diagnosed cancer in women worldwide. Over the past decade, the treatment paradigm for patients with metastatic breast canc... hormone receptor positive treatment options for patients frontiers https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.997346/full Frontiers | Case report: Clinical success targeting BRAF-mutated, hormone receptor positive, HER2-... Background: Hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer patients have had a wide range of therapeutical option... hormone receptor positive case report https://www.breastcancer.org/research-news/10-yrs-of-femara-better-than-5 10 Years of Femara Better Than 5 for Early-Stage, Hormone-Receptor-Positive Disease Ten years of Femara offers more benefits than 5 years. 10 years of https://www.uclahealth.org/news/release/promising-drug-doubled-positive-effect-hormone-receptor Promising Drug Doubled Positive Effect in Hormone-Receptor Positive Breast Cancer | UCLA Health https://www.breastcancer.org/research-news/65-plus-w-early-hr-pos-may-be-able-to-skip-rads Some Older Women With Early-Stage Hormone-Receptor-Positive Breast Cancer May Be Able to Skip... Some older women with early-stage hormone-receptor-positive breast cancer who have a lumpectomy followed by hormonal therapy treatment may skip radiation. https://www.aacr.org/about-the-aacr/newsroom/news-releases/camizestrant-may-be-superior-to-fulvestrant-in-patients-with-hormone-receptor-positive-her2-negative-breast-cancer/ Camizestrant May Be Superior to Fulvestrant in Patients With Hormone Receptor-positive,... Camizestrant May Be Superior to Fulvestrant in Patients With Hormone Receptor-positive, HER2-negative Breast Cancer may be https://www.breastcancer.org/podcast/kisqali-monaleesa-2 Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative... Dr. Gabriel Hortobagyi discusses overall survival results from the MONALEESA-2 trial. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-buparalisib-for-advanced-breast-cancer-that-is-hormone-receptor-positive-and-her2-negative-belle2 A trial of buparlisib for advanced breast cancer that is hormone receptor positive and HER2... This trial looked at a drug called buparlisib for breast cancer that had spread into tissue surrounding the breast or elsewhere in the body. https://www.breastcancer.org/research-news/reduced-treatment-seems-safe-for-some Reducing Treatment Seems Safe for Older Women With Early-Stage, Hormone-Receptor-Positive Breast... Skipping sentinel lymph node biopsy and/or radiation therapy seems safe for older women with early-stage, hormone-receptor-positive, breast cancer. https://www.mdpi.com/1422-0067/24/19/14777 Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive... Breast cancer remains the most frequently diagnosed cancer in women worldwide. Tumors that express hormone receptors account for 75% of all cases.... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06351&r=1 Avasopasem for the Treatment of Patients with Metastatic Hormone Receptor Positive, HER2 Negative... Avasopasem for the Treatment of Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer with Progression on a CDK4/6 Inhibitor and... https://www.nice.org.uk/guidance/ta810/evidence Evidence | Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive,... Evidence-based recommendations on abemaciclib (Verzenios) with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative,... endocrine therapy https://www.breastcancer.org/research-news/ibrance-w-faslodex-helps-advanced-hr-pos-survival Adding Ibrance to Faslodex Improves Overall Survival in Advanced-Stage, Hormone Receptor-Positive... The latest results from the PALOMA-3 trial show that adding Ibrance to Faslodex improves overall survival by about seven months compared to Faslodex alone. https://www.breastcancer.org/podcast/capivasertib Experimental Capivasertib Seems Promising for Advanced-Stage, Hormone Receptor-Positive,... Dr. Nicholas Turner explains research looking at capivasertib, a new targeted therapy medicine. for advanced hormone receptor experimental capivasertib seems

Robuta